Author

Sunil Kumar Joshi

Oregon Health & Science UniversityORCID 0000-0003-2798-5762Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Cancer Biology· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:proteomics· 2 Assay:scRNA-seq· 2 Approach:statistical model· 2 Research Focus:benchmarking· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1

Frequent Co-Authors

Elie A. TraeriD· 2 shared A. Danin· 1 shared Abraham BercovichiD· 1 shared Adam B. OlsheniD· 1 shared Alexander E. PerliD· 1 shared Alisa DamnernsawadiD· 1 shared Amos TanayiD· 1 shared Andrew Koh· 1 shared

Activity by Year

2021-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Elie A. TraerORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintFeb 2, 2025

RAS pathway activation drives clonal selection and monocytic differentiation in FLT3 and BCL2 inhibitor resistance

Vanessa Elaine Kennedy, Cheryl A.C. Peretz, Anushka Walia…·Catherine Choy Smith

4 citations

𝕏 PostBluesky

Molecular BiologybioRxivPreprintNov 30, 2023

Natural and age-related variation in circulating human hematopoietic stem cells

Nili Furer, Nadav Rappoport, Oren Milman…·LI Shlush

The paper characterizes age-related and inter-individual variation in circulating hematopoietic stem cells and establishes a normal reference to identify hematological disorders.

1 citation

𝕏 PostBluesky

BioinformaticsbioRxivPreprintJun 4, 2021

Utilizing proteomics and phosphoproteomics to predict ex vivo drug sensitivity across genetically diverse AML patients

Sara J.C. Gosline, Cristina E. Tognon, Michael D. Nestor…·Karin Rodland

The paper predicts ex vivo drug sensitivity in AML patients using proteomic and phosphoproteomic signatures, showing better accuracy than mutation or mRNA-based signatures.

DOI 10.1101/2021.06.04.447154

humanproteomics

𝕏 PostBluesky